keyword
MENU ▼
Read by QxMD icon Read
search

the lancet

keyword
https://www.readbyqxmd.com/read/29047431/the-link-between-cancer-and-obesity
#1
EDITORIAL
The Lancet
No abstract text is available yet for this article.
October 14, 2017: Lancet
https://www.readbyqxmd.com/read/29047430/who-launches-new-leadership-new-priorities
#2
EDITORIAL
The Lancet
No abstract text is available yet for this article.
October 14, 2017: Lancet
https://www.readbyqxmd.com/read/29047429/tobacco-control-a-foundation-too-far
#3
EDITORIAL
The Lancet
No abstract text is available yet for this article.
October 14, 2017: Lancet
https://www.readbyqxmd.com/read/29032993/alleviating-the-access-abyss-in-palliative-care-and-pain-relief-an-imperative-of-universal-health-coverage-the-lancet-commission-report
#4
REVIEW
Felicia Marie Knaul, Paul E Farmer, Eric L Krakauer, Liliana De Lima, Afsan Bhadelia, Xiaoxiao Jiang Kwete, Héctor Arreola-Ornelas, Octavio Gómez-Dantés, Natalia M Rodriguez, George A O Alleyne, Stephen R Connor, David J Hunter, Diederik Lohman, Lukas Radbruch, María Del Rocío Sáenz Madrigal, Rifat Atun, Kathleen M Foley, Julio Frenk, Dean T Jamison, M R Rajagopal
No abstract text is available yet for this article.
October 11, 2017: Lancet
https://www.readbyqxmd.com/read/29030092/a-phase-ii-study-of-clag-regimen-combined-with-imatinib-mesylate-for-relapsed-or-refractory-acute-myeloid-leukemia
#5
Abu-Sayeef Mirza, Jeffrey E Lancet, Kendra Sweet, Eric Padron, Javier Pinilla-Ibarz, Lisa Nardelli, Christopher Cubitt, Alan F List, Rami S Komrokji
INTRODUCTION: No standard salvage chemotherapy regimen is available for relapsed or refractory (RR) acute myeloid leukemia (AML). Preclinical data have suggested synergy in vitro between cytarabine and imatinib mesylate (IM) on AML cell growth inhibition. After demonstrating the safety and feasibility in a phase I study, we conducted a phase II clinical study of CLAG (cladribine, cytarabine, granulocyte colony-stimulating factor) regimen combined with IM for patients with RR-AML. PATIENTS AND METHODS: We performed a single-institution 2-stage phase II study...
September 19, 2017: Clinical Lymphoma, Myeloma & Leukemia
https://www.readbyqxmd.com/read/29029838/global-analysis-of-neurological-disease-burden-and-benefit
#6
EDITORIAL
The Lancet Neurology
No abstract text is available yet for this article.
November 2017: Lancet Neurology
https://www.readbyqxmd.com/read/29026859/molecular-identification-of-leishmania-species-in-a-re-emerged-focus-of-cutaneous-leishmaniasis-in-varamin-district-iran
#7
Mahmoodreza Behravan, Vahideh Moin-Vaziri, Ali Haghighi, Nourina Rahbarian, Niloofar Taghipour, Alireza Abadi, Homa Hajjaran
BACKGROUND: Cutaneous leishmaniasis (CL) is one of the most important neglected tropical diseases and a major public health challenge in Iran caused by Leishmania spp and transmitted by phlebotomine sand flies. The number of CL cases has shown an increasing pattern all over the country, including the district of Varamin, southeast of Tehran, Iran. This study aimed to identify the Leishmania spp isolated from CL patients using molecular methods in Varamin during 2012-2013. METHODS: Exudate materials collected from the swollen edge of the skin lesions of 44 parasitological positive CL patients by disposable lancet...
March 2017: Journal of Arthropod-borne Diseases
https://www.readbyqxmd.com/read/29025617/disaster-prevention-should-be-equal
#8
EDITORIAL
The Lancet Global Health
No abstract text is available yet for this article.
November 2017: Lancet Global Health
https://www.readbyqxmd.com/read/29022523/-best-buys-for-surgery-in-south-africa
#9
T Wilkinson, M Smith, A Kinghorn, K J Hofman
Improving access to basic surgical interventions has great potential to improve the length and quality of life of many people in low- and middle-income countries (LMICs). However, research has shown that current access to surgical interventions is limited, and initiatives such as the Lancet Commission on Global Surgery 2030 advocate for improved access to basic surgical interventions for all. As the needs, health system context and available budgets in each country will be different, a critical component of effective local scale-up of surgical interventions will be to use tools and processes of health technology assessment (HTA)...
September 22, 2017: South African Medical Journal, Suid-Afrikaanse Tydskrif Vir Geneeskunde
https://www.readbyqxmd.com/read/29017706/improving-uptake-of-colorectal-cancer-screening
#10
EDITORIAL
The Lancet Gastroenterology Hepatology
No abstract text is available yet for this article.
November 2017: Lancet. Gastroenterology & Hepatology
https://www.readbyqxmd.com/read/28993088/hip-and-knee-arthroplasty-orthopedic-literature-in-medical-journals-is-it-negatively-biased
#11
Ronald E Delanois, Chukwuweike U Gwam, Nicolas S Piuzzi, Morad Chughtai, Arthur L Malkani, Peter M Bonutti, Michael A Mont
BACKGROUND: Healthcare policy is often determined by well-designed studies most often published in high-impact medical journals. However, concern about the presence of publication bias against lower-extremity arthroplasty-related studies has called into question some of the validity of certain reports. There are only a few studies investigating the presence of the bias in high-impact medical journals against lower-extremity arthroplasty intervention, particularly in the Journal of American Medical Association (JAMA), New England Journal of Medicine (NEJM), and the Lancet...
September 19, 2017: Journal of Arthroplasty
https://www.readbyqxmd.com/read/28988717/where-are-the-innovations-in-tuberculosis-drug-discovery
#12
EDITORIAL
The Lancet Respiratory Medicine
No abstract text is available yet for this article.
October 4, 2017: Lancet Respiratory Medicine
https://www.readbyqxmd.com/read/28988181/search-for-unpublished-data-by-systematic-reviewers-an-audit
#13
Hedyeh Ziai, Rujun Zhang, An-Wen Chan, Nav Persaud
OBJECTIVES: We audited a selection of systematic reviews published in 2013 and reported on the proportion of reviews that researched for unpublished data, included unpublished data in analysis and assessed for publication bias. DESIGN: Audit of systematic reviews. DATA SOURCES: We searched PubMed and Ovid MEDLINE In-Process & Other Non-Indexed Citations between 1 January 2013 and 31 December 2013 for the following journals: Journal of the American Medical Association, The British Medical Journal, Lancet, Annals of Internal Medicine and the Cochrane Database of Systematic Reviews...
October 6, 2017: BMJ Open
https://www.readbyqxmd.com/read/28980947/the-vatican-mario-negri-lancet-commission-on-the-value-of-life
#14
Naomi Lee, Giuseppe Remuzzi, Richard Horton
No abstract text is available yet for this article.
September 30, 2017: Lancet
https://www.readbyqxmd.com/read/28980945/a-multisectoral-approach-to-childhood-development
#15
EDITORIAL
The Lancet
No abstract text is available yet for this article.
September 30, 2017: Lancet
https://www.readbyqxmd.com/read/28980944/accountability-is-key-for-protecting-health-workers
#16
EDITORIAL
The Lancet
No abstract text is available yet for this article.
September 30, 2017: Lancet
https://www.readbyqxmd.com/read/28980943/imagine-a-world-free-from-hunger-and-malnutrition
#17
EDITORIAL
The Lancet
No abstract text is available yet for this article.
September 30, 2017: Lancet
https://www.readbyqxmd.com/read/28973503/minding-the-gaps-health-financing-universal-health-coverage-and-gender
#18
Sophie Witter, Veloshnee Govender, T K Sundari Ravindran, Robert Yates
In a webinar in 2015 on health financing and gender, the question was raised why we need to focus on gender, given that a well-functioning system moving towards Universal Health Coverage (UHC) will automatically be equitable and gender balanced. This article provides a reflection on this question from a panel of health financing and gender experts.We trace the evidence of how health-financing reforms have impacted gender and health access through a general literature review and a more detailed case-study of India...
July 25, 2017: Health Policy and Planning
https://www.readbyqxmd.com/read/28971809/access-to-opioids-a-balance-of-harms
#19
EDITORIAL
The Lancet Oncology
No abstract text is available yet for this article.
October 2017: Lancet Oncology
https://www.readbyqxmd.com/read/28967629/mutations-in-aifm1-cause-an-x-linked-childhood-cerebellar-ataxia-partially-responsive-to-riboflavin
#20
G Heimer, E Eyal, X Zhu, E K Ruzzo, D Marek-Yagel, Doron Sagiv, Y Anikster, H Reznik-Wolf, E Pras, D Oz Levi, D Lancet, B Ben-Zeev, A Nissenkorn
BACKGROUND: AIFM1 encodes a mitochondrial flavoprotein with a dual role (NADH oxidoreductase and regulator of apoptosis), which uses riboflavin as a cofactor. Mutations in the X-linked AIFM1 were reported in relation to two main phenotypes: a severe infantile mitochondrial encephalomyopathy and an early-onset axonal sensorimotor neuropathy with hearing loss. In this paper we report two unrelated males harboring AIFM1 mutations (one of which is novel) who display distinct phenotypes including progressive ataxia which partially improved with riboflavin treatment...
September 15, 2017: European Journal of Paediatric Neurology: EJPN
keyword
keyword
52159
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"